Demonstration of advanced glycation end product (AGE) expression in bladder cancer tissue in type-2 diabetic and non-diabetic patients and the relationship between AGE accumulation and endoplasmic reticulum stress with bladder cancer.

International Journal of Clinical Practice
Kadir KarkinMustafa Zühtü Tansuğ

Abstract

This study aimed to investigate the relationship between advanced glycation end product (AGE) expression and accumulation in transurethral resection (TUR-B) material taken from type-2 diabetes mellitus (DM) and non-DM bladder cancer patients and endoplasmic reticulum stress (ERS) with bladder cancer. The patients who had TUR-B between May 2016 and September 2018 were included in the study. After the tissue samples had been taken and frozen at -80°C, they were homogenised to be used in enzyme-linked immunosorbent assay (ELISA) experiments. The patients were grouped as DM and non-DM. In both groups, mean AGE, IRE1, PERK and ATF6 expression amounts were evaluated through ELISA method in the pathological material. The expression amounts in tissue samples were AGE 0.59 ± 0.03 µg/mL, ATF6 1.08 ± 0.11 µg/mL, IRE1 30.71 ± 1.68 ng/mL, PERK 0.28 ± 0.02 ng. It was /mL. While there was no significant difference amongst AGE µg/mL (P = .146), ATF6 µg/mL (P = .175), IRE1 ng/mL (P = NA) and PERK ng/mL (P = .125) (P > .05) in the presence of DM, a positive correlation was observed between AGE values and PERK ng/mL values (r = .629; P < .05). Bladder cancer may develop as a result of accumulation of AGEs and ERS. Demonstration of the expression ...Continue Reading

References

Sep 19, 1991·The New England Journal of Medicine·Z MakitaH Vlassara
Jan 1, 1989·Critical Reviews in Food Science and Nutrition·J O'Brien, P A Morrissey
Oct 29, 1993·Biochemical and Biophysical Research Communications·S MikiT Kishimoto
Aug 1, 1996·Drugs & Aging·S R Thorpe, J W Baynes
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·T KoschinskyH Vlassara
Aug 16, 2001·Trends in Biochemical Sciences·A S Lee
Feb 28, 2003·Neurochemistry International·Barkur S Shastry
Oct 19, 2004·Microbes and Infection·Triantafyllos ChavakisPeter P Nawroth
Jul 23, 2005·Annals of the New York Academy of Sciences·Yasuhiko YamamotoHiroshi Yamamoto
Jul 23, 2005·Annals of the New York Academy of Sciences·Jeroen W J van HeijstCasper G Schalkwijk
Oct 6, 2006·Diabetologia·S C LarssonA Wolk
Apr 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jaime UribarriHelen Vlassara
Jun 15, 2007·Nature Reviews. Molecular Cell Biology·David Ron, Peter Walter
Sep 28, 2007·Current Pharmaceutical Design·Sho-ichi YamagishiSeiya Okuda
Mar 8, 2008·Current Opinion in Genetics & Development·Paola AllavenaAlberto Mantovani
Aug 19, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Susanna C LarssonAlicja Wolk
Jan 21, 2010·Critical Reviews in Toxicology·Annette BachandLaura E Carlton
May 19, 2010·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Richard D SembaLuigi Ferrucci
Jul 1, 2010·Diabetes Care·Edward GiovannucciDouglas Yee
Oct 22, 2010·Amino Acids·Ram H NagarajAlan W Stitt
May 17, 2011·Diabetes Technology & Therapeutics·Aleksandra AraszkiewiczDorota Zozulinska-Ziolkiewicz
Apr 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Rui KangHerbert J Zeh
Oct 2, 2012·International Journal of Cancer. Journal International Du Cancer·Christina C NewtonEric J Jacobs
Nov 17, 2012·Journal of Diabetes and Its Complications·Vincent M MonnierUNKNOWN DCCT Research Group
Jan 9, 2013·Cancer Causes & Control : CCC·Anna E PrizmentAaron R Folsom
Mar 5, 2013·Clinical Chemistry and Laboratory Medicine : CCLM·Christos AdamopoulosAthanasios G Papavassiliou
May 2, 2013·Diabetes Technology & Therapeutics·Julien VouillarmetCharles Thivolet
Jul 11, 2013·Cellular Signalling·Jianling XieMaría Montserrat Aguilar-Hernández
Dec 3, 2014·Journal of Cancer Research and Therapeutics·Zhengjun KangZhan Guo
Mar 19, 2015·Biomolecules·Kerstin NowotnyTilman Grune
Apr 10, 2015·Asian Pacific Journal of Cancer Prevention : APJCP·Hossein KhorramdelazadMehdi Abedinzadeh
May 25, 2016·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·J WojciechowskaT Zatoński
Jul 3, 2016·European Urology·Sebastien AntoniFreddie Bray
Jul 25, 2017·Medicina clínica·Roberto Hugo Martinez RodriguezLuis Ibarz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging-Associated Metabolic Disorders

Age is associated with many metabolic disorders including cardiovascular diseases, type 2 diabetes, stroke and heart disease. The mediators in aging process have been suggested to play a part in the cellular processes responsible for these metabolic disorders. Here is the latest research on aging-associated metabolic disorders.

Aging & Diabetes

This feed focuses on the role of the aging process on developing diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.